These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37811811)

  • 1. Molecular insights into the HLA-B35 molecules' classification associated with HIV control.
    Lobos CA; Chatzileontiadou DS; Sok B; Almedia CA; Halim H; D'Orsogna L; Gras S
    Immunol Cell Biol; 2024 Jan; 102(1):34-45. PubMed ID: 37811811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS.
    Gao X; Nelson GW; Karacki P; Martin MP; Phair J; Kaslow R; Goedert JJ; Buchbinder S; Hoots K; Vlahov D; O'Brien SJ; Carrington M
    N Engl J Med; 2001 May; 344(22):1668-75. PubMed ID: 11386265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Grouping HLA-B locus serologic specificities according to shared structural motifs suggests that different peptide-anchoring pockets may have contrasting influences on the course of HIV-1 infection.
    Itescu S; Rose S; Dwyer E; Winchester R
    Hum Immunol; 1995 Jan; 42(1):81-9. PubMed ID: 7751163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid progressing allele HLA-B35 Px restricted anti-HIV-1 CD8+ T cells recognize vestigial CTL epitopes.
    Willberg CB; Garrison KE; Jones RB; Meiklejohn DA; Spotts G; Liegler TJ; Ostrowski MA; Karlsson AC; Hecht FM; Nixon DF
    PLoS One; 2010 Apr; 5(4):e10249. PubMed ID: 20422053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of presentation of multiple HIV-1 cytotoxic T lymphocyte epitopes by HLA-B*3501 molecules that are associated with the accelerated progression of AIDS.
    Tomiyama H; Miwa K; Shiga H; Moore YI; Oka S; Iwamoto A; Kaneko Y; Takiguchi M
    J Immunol; 1997 May; 158(10):5026-34. PubMed ID: 9144523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of HLA-B*35 subtype differences on HIV disease outcome in Mexico.
    Juarez-Molina CI; Valenzuela-Ponce H; Avila-Rios S; Garrido-Rodriguez D; Garcia-Tellez T; Soto-Nava M; Garcia-Morales C; Goulder P; Reyes-Teran G
    AIDS; 2014 Jul; 28(11):1687-90. PubMed ID: 24853499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single CTL clone can recognize a naturally processed HIV-1 epitope presented by two different HLA class I molecules.
    Tomiyama H; Yamada N; Komatsu H; Hirayama K; Takiguchi M
    Eur J Immunol; 2000 Sep; 30(9):2521-30. PubMed ID: 11009085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women.
    Rowland-Jones S; Sutton J; Ariyoshi K; Dong T; Gotch F; McAdam S; Whitby D; Sabally S; Gallimore A; Corrah T
    Nat Med; 1995 Jan; 1(1):59-64. PubMed ID: 7584954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-B35 is associated with accelerated progression to AIDS.
    Itescu S; Mathur-Wagh U; Skovron ML; Brancato LJ; Marmor M; Zeleniuch-Jacquotte A; Winchester R
    J Acquir Immune Defic Syndr (1988); 1992; 5(1):37-45. PubMed ID: 1738086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crucial role of N-terminal residue of binding peptides in recognition of the monoclonal antibody specific for the peptide-HLA-B5, -B35 complex.
    Sakaguchi T; Takamiya Y; Edidin M; Nokihara K; Miwa K; Schönbach C; Takiguchi M
    Immunogenetics; 1998; 47(2):149-58. PubMed ID: 9396861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-B*35-Px-mediated acceleration of HIV-1 infection by increased inhibitory immunoregulatory impulses.
    Huang J; Goedert JJ; Sundberg EJ; Cung TD; Burke PS; Martin MP; Preiss L; Lifson J; Lichterfeld M; Carrington M; Yu XG
    J Exp Med; 2009 Dec; 206(13):2959-66. PubMed ID: 20008523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-B*35: 05 is a protective allele with a unique structure among HIV-1 CRF01_AE-infected Thais, in whom the B*57 frequency is low.
    Mori M; Wichukchinda N; Miyahara R; Rojanawiwat A; Pathipvanich P; Maekawa T; Miura T; Goulder P; Yasunami M; Ariyoshi K; Sawanpanyalert P
    AIDS; 2014 Apr; 28(7):959-67. PubMed ID: 24566094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological control of chronic HIV-1 infection: HLA-mediated immune function and viral evolution in adolescents.
    Bansal A; Yue L; Conway J; Yusim K; Tang J; Kappes J; Kaslow RA; Wilson CM; Goepfert PA
    AIDS; 2007 Nov; 21(18):2387-97. PubMed ID: 18025875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single T cell receptor-mediated recognition of an identical HIV-derived peptide presented by multiple HLA class I molecules.
    Ueno T; Tomiyama H; Takiguchi M
    J Immunol; 2002 Nov; 169(9):4961-9. PubMed ID: 12391209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collaboration of a Detrimental HLA-B*35:01 Allele with HLA-A*24:02 in Coevolution of HIV-1 with T Cells Leading to Poorer Clinical Outcomes.
    Kuse N; Murakoshi H; Akahoshi T; Chikata T; James KL; Gatanaga H; Rowland-Jones SL; Oka S; Takiguchi M
    J Virol; 2021 Nov; 95(23):e0125921. PubMed ID: 34523962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large scale mass spectrometric profiling of peptides eluted from HLA molecules reveals N-terminal-extended peptide motifs.
    Escobar H; Crockett DK; Reyes-Vargas E; Baena A; Rockwood AL; Jensen PE; Delgado JC
    J Immunol; 2008 Oct; 181(7):4874-82. PubMed ID: 18802091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid human immunodeficiency virus disease progression is associated with human leukocyte antigen-B homozygocity and human leukocyte antigen-B51 in a cohort from Manitoba, Canada.
    Keynan Y; Becker M; Rueda Z; Bresler K; Kasper K
    Infect Dis (Lond); 2015 Jul; 47(7):447-52. PubMed ID: 25746818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of multiple HIV-1 cytotoxic T-cell epitopes presented by human leukocyte antigen B35 molecules.
    Shiga H; Shioda T; Tomiyama H; Takamiya Y; Oka S; Kimura S; Yamaguchi Y; Gojoubori T; Rammensee HG; Miwa K; Takiguchi M
    AIDS; 1996 Sep; 10(10):1075-83. PubMed ID: 8874623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA class I associations with rates of HIV-1 seroconversion and disease progression in the Pumwani Sex Worker Cohort.
    Peterson TA; Kimani J; Wachihi C; Bielawny T; Mendoza L; Thavaneswaran S; Narayansingh MJ; Kariri T; Liang B; Ball TB; Ngugi EN; Plummer FA; Luo M
    Tissue Antigens; 2013 Feb; 81(2):93-107. PubMed ID: 23330720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-B*35-PX and HLA-B*35-PY subtype differentiation does not predict observed differences in level of HIV control in a Peruvian MSM cohort.
    Olvera A; Ganoza C; Pérez-Álvarez S; Hildebrand W; Sanchez J; Brander C
    AIDS; 2014 Sep; 28(15):2323-5. PubMed ID: 25313587
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.